Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Advancing stem cell biology toward stem cell therapeutics.

Literature DB >> 22305564

Advancing stem cell biology toward stem cell therapeutics.

Abstract

Here, the International Society for Stem Cell Research (ISSCR) Clinical Translation Committee introduces a series of disease-specific articles, outlining the challenges surrounding the clinical translation of stem cell therapeutics.

Entities: Disease Species

Mesh：

Year: 2012 PMID： 22305564 PMCID： PMC4020273 DOI： 10.1016/j.stem.2012.01.010

Source DB: PubMed Journal: Cell Stem Cell ISSN： 1875-9777 Impact factor: 24.633

Keyword Cloud
Cited

8 in total

1. Stem cells' guided gene therapy of cancer: New frontier in personalized and targeted therapy.

Authors: Maria Mavroudi; Paul Zarogoulidis; Konstantinos Porpodis; Ioannis Kioumis; Sofia Lampaki; Lonny Yarmus; Raf Malecki; Konstantinos Zarogoulidis; Marek Malecki
Journal: J Cancer Res Ther (Manch) Date: 2014

2. Cell-based therapeutics: the next pillar of medicine.

Authors: Michael A Fischbach; Jeffrey A Bluestone; Wendell A Lim
Journal: Sci Transl Med Date: 2013-04-03 Impact factor: 17.956

3. A scalable approach to prevent teratoma formation of human embryonic stem cells.

Authors: Zhili Rong; Xuemei Fu; Meiyan Wang; Yang Xu
Journal: J Biol Chem Date: 2012-08-04 Impact factor: 5.157

4. A single epidermal stem cell strategy for safe ex vivo gene therapy.

Authors: Stéphanie Droz-Georget Lathion; Ariane Rochat; Graham Knott; Alessandra Recchia; Danielle Martinet; Sara Benmohammed; Nicolas Grasset; Andrea Zaffalon; Nathalie Besuchet Schmutz; Emmanuelle Savioz-Dayer; Jacques Samuel Beckmann; Jacques Rougemont; Fulvio Mavilio; Yann Barrandon
Journal: EMBO Mol Med Date: 2015-04 Impact factor: 12.137

5. Safeguarding Stem Cell-Based Regenerative Therapy against Iatrogenic Cancerogenesis: Transgenic Expression of DNASE1, DNASE1L3, DNASE2, DFFB Controlled By POLA1 Promoter in Proliferating and Directed Differentiation Resisting Human Autologous Pluripotent Induced Stem Cells Leads to their Death.

Authors: Marek Malecki; Christine LaVanne; Dominique Alhambra; Chaitanya Dodivenaka; Sarah Nagel; Raf Malecki
Journal: J Stem Cell Res Ther Date: 2013-07-22

Advancing stem cell biology toward stem cell therapeutics.

1. Stem cells' guided gene therapy of cancer: New frontier in personalized and targeted therapy.

2. Cell-based therapeutics: the next pillar of medicine.

3. A scalable approach to prevent teratoma formation of human embryonic stem cells.

4. A single epidermal stem cell strategy for safe ex vivo gene therapy.

5. Safeguarding Stem Cell-Based Regenerative Therapy against Iatrogenic Cancerogenesis: Transgenic Expression of DNASE1, DNASE1L3, DNASE2, DFFB Controlled By POLA1 Promoter in Proliferating and Directed Differentiation Resisting Human Autologous Pluripotent Induced Stem Cells Leads to their Death.

6. 'Above all, do no harm': safeguarding pluripotent stem cell therapy against iatrogenic tumorigenesis.

7. A new class of pluripotent stem cell cytotoxic small molecules.

Review 8. Science, ethics and communication remain essential for the success of cell-based therapies.